Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × enzalutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 83 Prostatic Neoplasms, Castration-Resistant 10 Neoplasms 7 Neoplasm Metastasis 7 Breast Neoplasms 7 Carcinoma, Non-Small-Cell Lung 4 Small Cell Lung Carcinoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Metastatic Castration-Resistant Prostate Cancer 3 Melanoma 3 mCRPC 2 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostate Adenocarcinoma 2 Metastatic Hormone-sensitive Prostate Cancer 2 Metastatic Hormone Sensitive Prostate Cancer 2 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Bites and Stings 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Sleep Initiation and Maintenance Disorders 1 Salivary Cancer 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡